Venture-Backed BioAmber Sets IPO Terms
BioAmber Inc., which has developed a technology platform for converting renewable feedstocks into chemicals including succinic acid, announced IPO plans intended to raise US$128 million. The company, which has offices in Montréal and Minneapolis, Minnesota, will offer shares on the New York Stock Exchange. BioAmber completed its Series C round of venture capital financing totaling US$30 million in 2012. Its backers include Clifton Group, LANXESS, Mitsui, Naxos Capital and Sofinnova Partners.
15 April 2013•1 min read
